Home/Filings/4/0000899243-23-003743
4//SEC Filing

Larue Catherine 4

Accession 0000899243-23-003743

CIK 0001596946other

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 8:30 PM ET

Size

13.7 KB

Accession

0000899243-23-003743

Insider Transaction Report

Form 4
Period: 2023-01-31
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2023-01-31+4381,618 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-01-314381,312 total
    Ordinary Shares (438 underlying)
Holdings
  • Ordinary Share Option (Right to Buy)

    Exercise: $182.00Exp: 2030-10-31Ordinary Shares (340 underlying)
    340
  • Ordinary Shares Option (Right to buy)

    Exercise: $192.40Exp: 2030-09-01Ordinary Shares (519 underlying)
    519
  • Ordinary Share Option (Right to Buy)

    Exercise: $101.20Exp: 2031-10-31Ordinary Shares (601 underlying)
    601
  • Ordinary Share Option (Right to Buy)

    Exercise: $5.20Exp: 2032-10-31Ordinary Shares (1,000 underlying)
    1,000
  • Ordinary Share Option (Right to Buy)

    Exercise: $192.40Exp: 2030-09-01Ordinary Shares (54 underlying)
    54
Footnotes (7)
  • [F1]Restricted Stock Units convert into ordinary shares on a one-for-one basis.
  • [F2]All 519 options have vested and remain exercisable.
  • [F3]All 54 options have vested and remain exercisable.
  • [F4]All 340 options have vested and remain exercisable.
  • [F5]All 601 options have vested and remain exercisable.
  • [F6]On October 31, 2022, the Reporting Person was granted 1,750 restricted stock units, of which 438 have vested and have converted into ordinary shares. The remaining 1,312 restricted stock units will vest in three equal installments on April 30, 2023, July 31, 2023 and October 31, 2023.
  • [F7]The options vest and become exercisable on October 31, 2023.

Issuer

Quotient Ltd

CIK 0001596946

Entity typeother

Related Parties

1
  • filerCIK 0001823057

Filing Metadata

Form type
4
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 8:30 PM ET
Size
13.7 KB